{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:02:06Z","timestamp":1694635326274},"reference-count":59,"publisher":"BMJ","issue":"6764","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1990,12,8]]},"DOI":"10.1136\/bmj.301.6764.1290","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"1290-1291","source":"Crossref","is-referenced-by-count":2,"title":["New directions in primary biliary cirrhosis."],"prefix":"10.1136","volume":"301","author":[{"given":"M C","family":"Bateson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"377","article-title":"The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?","volume":"276","author":"Myszor, M.; James, O.F.W.","year":"1990","unstructured":"Myszor M, James OFW. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q7 Med 1990;276:377-85.","journal-title":"Q7 Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840110317","article-title":"Epidemiology ofprimary biliary cirrhosis in a defined rural population in the northern part of Sweden","volume":"11","author":"Danielsson, A.; Boqvist, L.; Uddenfeldt, P.","year":"1990","unstructured":"Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology ofprimary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990;11:458-64.","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg, A.; Loof, L.","year":"1989","unstructured":"Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand_J Gastroenterol 1989;24:57-64.","journal-title":"Scand_J Gastroenterol"},{"key":"ref_4","first-page":"307","article-title":"La cirrhose biliaire primitive: modes actuels de presentation","volume":"4","author":"Brenard, R.; Degos, F.; Degott, C.; Lassoued, K.; Benhamou, J.P.","year":"1990","unstructured":"Brenard R, Degos F, Degott C, Lassoued K, Benhamou JP. La cirrhose biliaire primitive: modes actuels de presentation. Gastroenterol Clin Biol 1990;4:307-12.","journal-title":"Gastroenterol Clin Biol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(90)90968-7","article-title":"Symptom development and prognosis in PBC: a study in 2 centres","volume":"99","author":"Mitchison, H.C.; Lucey, M.R.; Kelly, P.J.; Neuberger, J.M.; Williams, R.; James, O.F.W.","year":"1990","unstructured":"Mitchison HC, Lucey MR, Kelly PJ, Neuberger JM, Williams R, James OFW. Symptom development and prognosis in PBC: a study in 2 centres. Gastroenterology 1990;99:778-84.","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficacy of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus, B.H.; Dickson, E.R.; Grambsch, P.M.","year":"1989","unstructured":"Markus BH, Dickson ER, Grambsch PM, et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N EnglJ Med 1989;320:1709-13.","journal-title":"N EnglJ Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/gut.31.9.1069","article-title":"Referral of patients with PBC for liver transplantation","volume":"31","author":"Neuberger, J.; Gunson, B.M.; Buckels, J.A.C.; Elias, E.; McMaster, P.","year":"1990","unstructured":"Neuberger J, Gunson BM, Buckels JAC, Elias E, McMaster P. Referral of patients with PBC for liver transplantation. Gut 1990;31:1069-72.","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0016-5085(55)80027-3","article-title":"Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis","volume":"28","author":"Carman, C.T.; Giansiracusa, J.E.","year":"1955","unstructured":"Carman CT, Giansiracusa JE. Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis. Gastroenterology 1955;28:193-215.","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1 year trial of prednisolone treatment in PBC: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison, H.C.; Bassendine, M.F.; Malcolm, A.J.; Watson, A.J.; Record, C.O.; James, O.F.W.","year":"1989","unstructured":"Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OFW. A pilot, double-blind, controlled 1 year trial of prednisolone treatment in PBC: hepatic improvement but greater bone loss. Hepatology 1989;10:420-9.","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in PBC","volume":"i:","author":"Epstein 0, Jain S, Lee RG","year":"1981","unstructured":"Epstein 0, Jain S, Lee RG, et al. D-penicillamine treatment improves survival in PBC. Lancet 1981;i: 1275-9.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double-blind controlled trial of penicillamine in PBC","volume":"26","author":"Neuberger, J.; Christensen, E.; Portman, B.","year":"1985","unstructured":"Neuberger J, Christensen E, Portman B, et al. Double-blind controlled trial of penicillamine in PBC. Gut 1985;26:114-9.","journal-title":"Gut"},{"key":"ref_12","first-page":"113942","article-title":"A prospective clinical trial of D-penicillamine in the treatment of PBC","volume":"5","author":"Bodenheimer, H.C.; Schaffner, F.; Sternlieb, I.; Killon, F.M.; Vemace, S.; Pezzullo, J.","year":"1985","unstructured":"Bodenheimer HC, Schaffner F, Sternlieb I, Killon FM, Vemace S, Pezzullo J. A prospective clinical trial of D-penicillamine in the treatment of PBC. Hepatology 1985;5:113942.","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","year":"1988","unstructured":"Thomton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988;297: 1501-4.","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.1840070420","article-title":"Effect of estradiol upon serum enzymes in PBC","volume":"7","author":"Guattery, J.M.; Faloon, W.W.","year":"1987","unstructured":"Guattery JM, Faloon WW. Effect of estradiol upon serum enzymes in PBC. HepatoloV 1987;7: 737-42","journal-title":"HepatoloV"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in PBC","volume":"89","author":"Christensen, E.; Neuberger, J.; Crowe, J.","year":"1985","unstructured":"Christensen E, Neuberger J, Crowe J, et al. Beneficial effect of azathioprine and prediction of prognosis in PBC. Gastroenierology 1985;89:1084-91.","journal-title":"Gastroenierology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote, J.; Ross, A.; Sherlock, S.","year":"1976","unstructured":"Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976;70:656-60.","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomised trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle, J.H.; Davis, G.L.; Schafer, D.F.","year":"1986","unstructured":"Hoofnagle JH, Davis GL, Schafer DF, et al. Randomised trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986;91:1327-34.","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporin in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner, R.H.; Ludwig, J.; Lindor, K.D.","year":"1990","unstructured":"Wiesner RH, Ludwig J, Lindor KD, et al. A controlled trial of cyclosporin in the treatment of primary biliary cirrhosis. N EnglJ3 Med 1990;322:1419-24.","journal-title":"N EnglJ3 Med"},{"key":"ref_19","first-page":"740","article-title":"Successful treatment of primary biliary cirrhosis with ciclosporine","volume":"115","author":"Lie, T.S.; Preissinger, H.","year":"1990","unstructured":"Lie TS, Preissinger H. Successful treatment of primary biliary cirrhosis with ciclosporine. Deutsche Medizinische Wochenschnzft 1990;115:740-2.","journal-title":"Deutsche Medizinische Wochenschnzft"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(88)90373-3","article-title":"Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis","volume":"95","author":"Minuk, G.Y.; Bohme, C.E.; Burgess, E.","year":"1988","unstructured":"Minuk GY, Bohme CE, Burgess E, et al. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 1988;95:1356-63.","journal-title":"Gastroenterology"},{"key":"ref_21","first-page":"340","article-title":"Effect of cyclosporine and cyclosporine plus prednisolone in primary","volume-title":"biliary cirrhosis. Transplant Proc 1988","volume":"20","author":"Beukers, R.; Schalm, S.W.","unstructured":"Beukers R, Schalm SW. Effect of cyclosporine and cyclosporine plus prednisolone in primary biliary cirrhosis. Transplant Proc 1988;20:340-3."},{"key":"ref_22","first-page":"1123","article-title":"Acute reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis","volume":"16","author":"Clegg, D.O.; Furst, D.E.; Tolman, K.G.; Pogue, R.","year":"1989","unstructured":"Clegg DO, Furst DE, Tolman KG, Pogue R. Acute reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis. J Rheumatol 1989;16:1123-6.","journal-title":"J Rheumatol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primar biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan, M.M.; Knox, T.A.; Arora, S.","year":"1988","unstructured":"Kaplan MM, Knox TA, Arora S. Primar biliary cirrhosis treated with low-dose oral pulse methotrexate. Ann Intern Med 1988;109:429-3 1.","journal-title":"Ann Intern Med"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/pgmj.58.685.701","article-title":"A clinical trial of levamisole in primary biliary cirrhosis","volume":"58","author":"Hishon, S.; Tobin, G.; Ciclitira, P.J.","year":"1982","unstructured":"Hishon S, Tobin G, Ciclitira PJ. A clinical trial of levamisole in primary biliary cirrhosis. Postgrad Med3r 1982;58:701-3.","journal-title":"Postgrad Med3r"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan, M.M.; Alling, D.W.; Zimmerman, H.J.; etal","year":"1986","unstructured":"Kaplan MM, Alling DW, Zimmerman HJ, etal. A prospective trial of colchicine for primary biliary cirrhosis. N EnglJ Med 1986;315:1448-54.","journal-title":"N EnglJ Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the treatment of cirrhosis of the liver","volume":"318","author":"Kershenobich, D.; Vargas, F.; Garcia-Tsao, G.; Tamayo, R.P.; Rojkind, M.","year":"1988","unstructured":"Kershenobich D, Vargas F, Garcia-Tsao G, Tamayo RP, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N EnglJ3 Med 1988;318:1709-13.","journal-title":"N EnglJ3 Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Bodenheimer, H.; Schaffner, F.; Pezzullo, J.","year":"1988","unstructured":"Bodenheimer H, Schaffner F, Pezzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988;95: 124-9.","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report","volume":"5","author":"Warnes, T.W.; Smith, A.; Fl, Lee; Haboubi, N.Y.; Johnson, P.; Hunt, L.","year":"1987","unstructured":"Warnes TW, Smith A, Lee Fl, Haboubi NY, Johnson P, Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol 1987;5:1-7.","journal-title":"J Hepatol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0016-5085(87)90249-6","article-title":"Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis","volume":"93","author":"Finklestein, M.; Goldman, L.; Grace, N.D.; Foely, M.; Randall, N.","year":"1987","unstructured":"Finklestein M, Goldman L, Grace ND, Foely M, Randall N. Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis. Gastroenterology 1987;93:1231-5.","journal-title":"Gastroenterology"},{"key":"ref_30","first-page":"1208","article-title":"Gallstone dissolution in patients with chronic active hepatitis","volume":"80","author":"Leuschner, U.; Leuschner, M.; Hubner, K.","year":"1981","unstructured":"Leuschner U, Leuschner M, Hubner K. Gallstone dissolution in patients with chronic active hepatitis. Gastroenterology 1981;80:A1208.","journal-title":"Gastroenterology"},{"key":"ref_31","first-page":"834","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary citrhosis?","volume":"i:","author":"Poupon, R.; Poupon, R.E.; Calmus, Y.; Ballet, F.; Darnis, F.","year":"1987","unstructured":"Poupon R, Poupon RE, Calmus Y, Ballet F, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary citrhosis? Lancet 1987;i:834-6.","journal-title":"Lancet"},{"key":"ref_32","first-page":"881","article-title":"Tauroursodeoxycholate reduces ductular proliferation and portal inflammation in bile-duct-ligated hamsters","volume":"80","author":"Krol, T.; Kitamura, T.; Miyai, K.; Hardison, W.","year":"1983","unstructured":"Krol T, Kitamura T, Miyai K, Hardison W. Tauroursodeoxycholate reduces ductular proliferation and portal inflammation in bile-duct-ligated hamsters. Hepatology 1983;80:A881.","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/BF01317087","article-title":"A) Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes","volume":"29","author":"Miyazaki, K.; Nakayama, F.; Koga","year":"1984","unstructured":"Miyazaki K, Nakayama F, Koga A) Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig Dis Sci 1984;29:1123-30.","journal-title":"Dig Dis Sci"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","article-title":"Characterisation of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment","volume":"30","author":"Batta, A.K.; Arora, R.; Salen, G.; Tint, G.S.; Eskreis, D.; Katz, S.","year":"1989","unstructured":"Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S. Characterisation of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. I Lipid Res 1989;30:1953-62.","journal-title":"I Lipid Res"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(87)92421-4","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"ii:","author":"Hofmann, A.F.; Popper, H.","year":"1987","unstructured":"Hofmann AF, Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987;ii:398-9.","journal-title":"Lancet"},{"key":"ref_36","first-page":"12","article-title":"Expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis; effect of UDCA","volume":"11","author":"Calmus, V.; Gane, P.; Rouger, P.; Poupon, R.","year":"1989","unstructured":"Calmus V, Gane P, Rouger P, Poupon R. Expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis; effect of UDCA. Hepatology 1989;11: 12-5.","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(89)92888-2","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis","volume":"i:","author":"Bateson, M.C.; Ross, P.E.; Diffey, B.L.","year":"1989","unstructured":"Bateson MC, Ross PE, Diffey BL. Ursodeoxycholic acid in primary biliary cirrhosis. Lancet 1989;i:898-9.","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01536665","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda, M.; Ghezzi, C.; Battezzati, P.M.","year":"1989","unstructured":"Podda M, Ghezzi C, Battezzati PM, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989;34:59-65S.","journal-title":"Dig Dis Sci"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner, U.; Fischer, H.; Kurtz, W.","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989;97:1268-74.","journal-title":"Gastroenterology"},{"key":"ref_40","first-page":"15","article-title":"Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis","volume":"85","author":"Matsuzaki, Y.; Tanaka, N.; Osuga, T.","year":"1990","unstructured":"Matsuzaki Y, Tanaka N, Osuga T, et al. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. Am 7 Gastroenterol 1990;85:15-23.","journal-title":"Am 7 Gastroenterol"},{"key":"ref_41","first-page":"IX","article-title":"Ursodeoxycholic acid 750 mg versus 1000 mg daily for primary biliary cirrhosis","volume":"20","author":"Bateson, M.C.","year":"1990","unstructured":"Bateson MC. Ursodeoxycholic acid 750 mg versus 1000 mg daily for primary biliary cirrhosis. Hepatology Rapid Literature Review 1990;20:IX-X.","journal-title":"Hepatology Rapid Literature Review"},{"key":"ref_42","first-page":"595","article-title":"The effect of UDCA in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis","volume":"94","author":"Stiehl, A.; Raedsch, R.; Kommerell, B.","year":"1988","unstructured":"Stiehl A, Raedsch R, Kommerell B. The effect of UDCA in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis. Gastroenterology 1988;94:A595.","journal-title":"Gastroenterology"},{"key":"ref_43","first-page":"1044","article-title":"Effects ofursodeoxycholic acid and taurine on serum liver enzymes and bile acids","volume-title":"chronic hepatitis. Gastroenterology 1990","volume":"98","author":"Podda, M.; Ghezzi, C.; Battezzati, P.M.; Crosignani, A.; Zuin, M.; Roda, A.","unstructured":"Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Effects ofursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology 1990;98: 1044-50."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up","volume":"30","author":"Leuschner, U.; Leuschner, M.; Sieratzki, M.L.; Kurtz, W.; Hubner, K.","year":"1985","unstructured":"Leuschner U, Leuschner M, Sieratzki ML, Kurtz W, Hubner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. Dig Dis Sci 1985;30:642-9.","journal-title":"Dig Dis Sci"},{"key":"ref_45","article-title":"Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation","author":"Ullrich, D.; Rating, D.; Schroter, W.; Hanefeld, F.; Bircher, J.","year":"1987","unstructured":"Ullrich D, Rating D, Schroter W, Hanefeld F, Bircher J. Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 1987;ii: 1324.","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0140-6736(90)91564-Q","article-title":"Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients","volume":"336","author":"Persson, H.; Friman, S.; Schersten, T.; Svanvik, J.; Karlberg, I.","year":"1990","unstructured":"Persson H, Friman S, Schersten T, Svanvik J, Karlberg I. Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet 1990;336:52-3.","journal-title":"Lancet"},{"key":"ref_47","first-page":"7","article-title":"Effect of ursodeoxycholic acid treatment on alanine amino-transferase and y-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial","volume":"8","author":"Bellentani, S.; Tabarroni, G.; Barchi, T.","year":"1989","unstructured":"Bellentani S, Tabarroni G, Barchi T, et al. Effect of ursodeoxycholic acid treatment on alanine amino-transferase and y-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.J7 Hepatol 1989;8:7-12."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.1840120221","article-title":"Comprehensive study of biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration","volume":"12","author":"Nakagawa, M.; Colombo, C.; Setchell, K.D.R.","year":"1990","unstructured":"Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 1990;12:322-34.","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0016-5085(90)91038-8","article-title":"Asymptomatic primary sclerosing cholangitis treated with UDCA","volume":"99","author":"Hayashi, H.; Higuchi, T.; Khimniya, A.; Hishida, N.; Sakamoto, N.","year":"1990","unstructured":"Hayashi H, Higuchi T, Khimniya A, Hishida N, Sakamoto N. Asymptomatic primary sclerosing cholangitis treated with UDCA. Gastroenterology 1990;99:533-5.","journal-title":"Gastroenterology"},{"key":"ref_50","first-page":"645","article-title":"Gall stone calcification caused by ursodeoxycholic acid","volume":"283","author":"Bateson, M.C.; Maudgal, D.P.; Trash, D.B.; Northfield, T.C.; Bouchier, I.A.D.","year":"1981","unstructured":"Bateson MC, Maudgal DP, Trash DB, Northfield TC, Bouchier IAD. Gall stone calcification caused by ursodeoxycholic acid. BMJ7 1981;283:645-6."},{"key":"ref_51","first-page":"598","article-title":"Effect of UDCA on liver function and pruritus in primary biliary cirrhosis","volume":"98","author":"Kneppelhout, J.C.; Mulder, C.J.J.; van Henegouwen, G.P.; de Vries, R.A.; Brandt, K.H.","year":"1990","unstructured":"Kneppelhout JC, Mulder CJJ, van Henegouwen GP, de Vries RA, Brandt KH. Effect of UDCA on liver function and pruritus in primary biliary cirrhosis. Gastroenterology 1990;98:A598.","journal-title":"Gastroenterology"},{"key":"ref_52","first-page":"617","article-title":"Ursodiol treatment of primary biliary cirrhosis","volume":"98","author":"O'Brien, C.B.; Senior, JR, Sternlieb; J.M.","year":"1990","unstructured":"O'Brien CB, Senior JR, Sternlieb JM, et al. Ursodiol treatment of primary biliary cirrhosis. Gastroenterology 1990;98:617.","journal-title":"Gastroenterology"},{"key":"ref_53","first-page":"284","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III","volume":"10","author":"Lotterer, E.; Stiehl, A.; Raedsch, R.; Foelsch, U.R.; Bircher, J.","year":"1990","unstructured":"Lotterer E, Stiehl A, Raedsch R, Foelsch UR, Bircher J. Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III. J7 Hepatol 1990;10:284-90."},{"key":"ref_54","first-page":"1163","article-title":"Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid","volume":"i:","author":"Vogel, W.; Kathrein, H.; Judmaier, G.; Braunsteiner, H.","year":"1988","unstructured":"Vogel W, Kathrein H, Judmaier G, Braunsteiner H. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet 1988;i: 1163.","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00001574-198801000-00002","article-title":"Neoplasms: epidemiology and aetiology","volume":"4","author":"Hill, M.","year":"1988","unstructured":"Hill M. Neoplasms: epidemiology and aetiology. Current Opinion in Gastroenterologv 1988;4:3-8.","journal-title":"Current Opinion in Gastroenterologv"},{"key":"ref_56","first-page":"163","article-title":"Chronic ursodeoxycholic acidand chenodeoxycholic acid-feeding-induced changes of colon mucosal cell proliferation in rats","volume":"79","author":"Simanowski, U.A.; Seitz, H.K.; Czygan, P.","year":"1987","unstructured":"Simanowski UA, Seitz HK, Czygan P, et al. Chronic ursodeoxycholic acidand chenodeoxycholic acid-feeding-induced changes of colon mucosal cell proliferation in rats. JNCI 1987;79:163-6.","journal-title":"JNCI"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0022-4731(87)90064-1","article-title":"Faecal steroid loss in healthy subjects during shortterm treatment with ursodeoxycholic acid","volume":"26","author":"Owen, R.W.; Dodd, M.; Thompson, M.H.; Hill, M.J.","year":"1987","unstructured":"Owen RW, Dodd M, Thompson MH, Hill MJ. Faecal steroid loss in healthy subjects during shortterm treatment with ursodeoxycholic acid. J Steroid Biochem 1987;26:503-7.","journal-title":"J Steroid Biochem"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00365529009107932","article-title":"Factors of prognostic importance in primary biliary cirrhosis","volume":"25","author":"Rydning, A.; Schrumpf, E.; Abdelnoor, M.; Elgio, K.; Jenssen, E.","year":"1990","unstructured":"Rydning A, Schrumpf E, Abdelnoor M, Elgio K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. ScandJ Gastroenterol 1990;25:119-26.","journal-title":"ScandJ Gastroenterol"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam, K.; Grambsch, P.M.; Wiesner, R.H.; Lindoe, K.D.; Dickson, E.R.","year":"1990","unstructured":"Balasubramaniam K, Grambsch PM, Wiesner RH, Lindoe KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990;98: 1567-71.","journal-title":"Gastroenterology"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.301.6764.1290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T23:04:56Z","timestamp":1633302296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.301.6764.1290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12,8]]},"references-count":59,"journal-issue":{"issue":"6764","published-print":{"date-parts":[[1990,12,8]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.301.6764.1290","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12,8]]}}}